Diabetes and Renal Failure

Advanced Renal Care

Volumn , Issue , 2008, Pages 122-133

  Youngman, Sara ^a  

^a ST HELIER HOSPITAL   (United Kingdom)

Author keywords

Diabetes; Kidney; Post medication measurements; Renal failure; Renal replacement

Indexed keywords

EID: 84873824574     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470693995.ch8     Document Type: Chapter

References (36)

1. ACE Inhibitors in Diabetic Nephropathy Trialist Group (2001) Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta analysis of individual patient data. Annals of Internal Medicine 134, 370-379.
2. Adler, A.L., Stratton, I.M., Neil, H.A., et al. (2000) Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): a prospective observational study. British Medical Journal 321, 412.
3. Andrews, P.A. and Brecker, S.J. (2002) Premature arteriosclerosis associated with diabetic renal disease. British Journal of Diabetes and Vascular Disease 2 (2), 128-9.
4. Chaplin, S. (2003) Key messages of the National Service Framework for Diabetes: delivery strategy. Practical Diabetes International 20 (1).
5. DAFNE Study Group (2002) Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised control trial. British Medical Journal 325, 746.
6. Department of Health (2002) The Expert Patient. A New Approach to Chronic Disease Management for 21st Century. Department of Health, London.
7. Department of Health (2003) National Service Framework for Diabetes: Delivery Strategy. www.doh.gov.uk/nsf/diabetes.
8. Haffner, S.M., Alexander, C.M., Cook, T.J., et al. (1999) Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose level: subgroup analysis in the Scandinavian Simvastatin Survival Study. Archives of International Medicine 159 (22), 2661-7.
9. Hanson Zanchetti, A. and Carruthers, S.G. (1998) Effects of the intensive bloodpressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 351, 1755.
10. Harvey, J.N., Rizvi, K., Craney, L., Messenger, J., Shah, R. and Meadows, P.A. (2001) Population based survey and analysis of trends in the prevalence of diabetic nephropathy in type 1 diabetes. Diabetes Medicine 18 (12) , 998-1002.
11. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators (2002) The effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus. Results of the HOPE and MICRO HOPE substudy. Lancet 355 (9200), 253-9.
12. Hill, M.N., Feldman, H.I., Hilton, S.C., Holechek, M.J., Ylitalo, M. and Benedict, G.W. (1996) Risk of foot complications in long-term diabetic patients with and without ESRD: a preliminary study. ANNA Journal 23 (4), 381-6.
13. Joint National Committee (1997) The sixth report on the Joint National Committee in detection, evaluation and treatment of high blood pressure. Archives of International Medicine 157, 2413.
14. Kaplin, N.M. and Gifford, R.W. (1996) Choice of initial therapy for hypertension. JAMA 275 (20), 1577-80.
15. Kirby, M. (2002) Screening for microalbuminuria. British Journal of Diabetes and Vascular Disease 2 (2), 106-109.
16. Knowles, A. (1998) Care of the diabetic foot. Journal of Wound Care 6 (5), 227-30.
17. Locatelli, F., Canaud, B., Eckardt, K.U., Stenvinkel, P., Wanner, C. and Zoccali, C. (2003) The importance of diabetic nephropathy in current nephrological practice. Nephrology Dialysis Transplantation 18 (9), 1716-25.
18. Lovell, B.H., Blasé, A., Beverley, H. and Carabello, B.A. (2000) Left ventricular hypertrophy pathogenesis, detection and prognosis. Circulation 4, 102-470.
19. McMurray, S.D., Johnson, G., Davis, S. and McDougall, K. (2002) Diabetes education and care management significantly improve patient outcomes in the dialysis unit. American Journal of Kidney Diseases 40 (3), 566-75.
20. Maynard, C. and Cordonnier, D. (2001) The late referral of diabetic patients with renal insufficiency to nephrologist has a high human and financial cost. Diabetes Metabolism 27, 517-21.
21. Mogensen, C.E., Keane, W.F., Bennett, P.H., Jerums, G., Parving, H.H., Passa, P., Steffes, M.W., Striker, G.E. and Viberti, G.C. (1995) Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 346 (8982), 1080-84.
22. NICE Guideline (2002) Management of Type 2 Diabetes-Renal Disease, Prevention and Early Management. www.nice.org.uk.
23. Navorro, X., Sutherland, D.E. and Kennedy, W.R. (1997) Long term effects of pancreatic transplantation on diabetic nephropathy. Annals of Neurology 42 (5), 727-36.
24. Ramsey, L.E., Williams, B. and Johnston, G.D. (1999) British Hypertension Society guidelines for hypertension management. British Medical Journal 319, 630.
25. Ravani, P., Marcelli, D. and Malberti, F. (2002) Vascular access surgery managed by renal physicians: the choice of native arteriovenous fistulas for hemodialysis. American Journal of Kidney Diseases 40 (6), 1264-76.
26. Reddy, K.S., Stablein, D., Taranto, S., Stratta, R.J., Johnston, T.D., Waid, T.H., McKeown, J.W., Lucas, B.A. and Ranjan, D. (2003) Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure. American Journal of Kidney Diseases 41 (2), 464-70.
27. Renderee, H.A., Omar, H.A., Motala, A.A. and Seedat, M.A. (1992) Effect of insulin therapy on blood pressure in NIDDM patients with secondary failure. Diabetes Care 15, 1258.
28. Renal Registry (2002) The Fifth Annual Renal Registry Report. www.renalreg.com.
29. Tabaei, B.P., Al-Kassab, A.S., Ilag, L.L., Zawacki, C.M. and Herman, W.H. (2001) Does microalbuminuria predict diabetic nephropathy? Diabetes Care 24 (9), 1560-66.
30. Tarnow, L., Rossing, P., Jenson, C. and Parving, H.H. (1999) The long term effect of nisoldipine and lisinipril in type 1 diabetic patients with diabetic nephropathy. Diabetes Care 23 (12), 1723-4.
31. World Health Organization (1999) International Society of Hypertension guidelines for the management of hypertension. Journal of Hypertension 17 (20), 151-83.
32. DCCT Research Group (1992) Lipid and lipoprotein levels in patients with IDDM: diabetes control and complications trial experience. Diabetes Care 15, 886.
33. DCCT Research Group (1993) Treatment of diabetes in the development and progression of long term complication in insulin-dependent diabetes. New England Journal of Medicine 329, 977-86.
34. DCCT Research Group (1995) The effect of Intensive therapy on the development and progression of diabetic nephropathy in the Diabetes and Complications Trial. Kidney International 47 (6), 1703-1720.
35. Lameire, N. (2000) Pathogenesis and treatment of diabetic nephropathy. EDTNA/ERCA Journal 26 (2), 8-10.
36. UK Prospective Diabetes Study Group (1998) Tight blood pressure control and the risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. British Medical Journal 317, 703-713.